Complete Filing Data
PolyPid Ltd. reported Stockholders Equity of $10.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PolyPid Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$34.2M | -$29.0M | -$23.9M | -$39.6M | -$42.6M | -$36.9M | -$6.9M | $5.9M |
| Research And Development Expense | $23.8M | $22.8M | $16.1M | $28.0M | $30.6M | $17.0M | $14.1M | $12.6M |
| Operating Income Loss | -$33.0M | -$28.0M | -$22.9M | -$38.9M | -$43.1M | -$26.3M | -$18.6M | -$18.4M |
| Nonoperating Income Expense | -$685.0K | -$951.0K | -$929.0K | -$540.0K | $544.0K | -$10.6M | $11.7M | $24.3M |
| General And Administrative Expense | $7.2M | $4.3M | $5.5M | $8.0M | $9.6M | $7.7M | $3.6M | $5.3M |
| Income Tax Expense Benefit | $5.0K | $42.0K | $69.0K | $129.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.2M | -$29.0M | -$23.8M | -$39.4M | -$42.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $11.0M | $7.7M | -$2.1M | $5.8M | $36.0M | $72.8M | -$87.6M | -$81.7M | -$88.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.6M | $15.8M | $5.7M | $9.1M | $10.5M | $4.9M | $4.5M | $7.8M | $4.1M |
| Cash And Cash Equivalents At Carrying Value | $6.4M | $15.6M | $5.3M | $8.6M | $9.8M | $4.3M | $3.9M | ||
| Retained Earnings Accumulated Deficit | -$301.5M | -$267.3M | -$238.3M | -$214.4M | -$174.9M | -$132.3M | -$93.3M | ||
| Restricted Cash Current | $193.0K | $168.0K | $300.0K | $511.0K | $397.0K | $390.0K | $375.0K | ||
| Property Plant And Equipment Net | $5.1M | $6.1M | $7.6M | $9.2M | $8.8M | $5.9M | $6.1M | ||
| Other Assets Noncurrent | $311.0K | $277.0K | $87.0K | $99.0K | $663.0K | $637.0K | $230.0K | ||
| Liabilities Current | $7.7M | $12.7M | $7.3M | $8.6M | $8.1M | $2.9M | $2.6M | ||
| Liabilities And Stockholders Equity | $22.3M | $25.2M | $15.4M | $26.0M | $44.2M | $75.8M | $33.8M | ||
| Assets Current | $15.2M | $16.6M | $6.1M | $14.2M | $34.8M | $47.2M | $27.4M | ||
| Assets | $22.3M | $25.2M | $15.4M | $26.0M | $44.2M | $75.8M | $33.8M | ||
| Accounts Payable Trade Current | $2.9M | $2.4M | $772.0K | $1.1M | $4.1M | $974.0K | $1.6M | ||
| Restricted Cash And Cash Equivalents At Carrying Value | $193.0K | $168.0K | $300.0K | $511.0K | $397.0K | $390.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $10.1M | -$3.5M | -$1.3M | $5.5M | $410.0K | -$3.3M | $3.7M | ||
| Repayments Of Long Term Debt | $6.4M | $3.3M | $2.6M | $402.0K | |||||
| Long Term Debt Current | $988.0K | $6.8M | $4.0M | $4.0M | |||||
| Accrued Liabilities And Other Liabilities | $2.7M | $2.6M | $2.0M | $2.4M | $3.9M | ||||
| Operating Lease Liability Noncurrent | $647.0K | $1.3M | $857.0K | $1.2M | |||||
| Operating Lease Liability Current | $1.2M | $919.0K | $540.0K | $959.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $287.0K | $1.5M | $241.0K | $3.5M | |||||
| Prepaid Expense And Other Assets Current | $995.0K | $764.0K | $458.0K | $1.1M | |||||
| Other Liabilities | $398.0K | $294.0K | $199.0K | $193.0K | $251.0K | ||||
| Operating Lease Right Of Use Asset | $1.7M | $2.3M | $1.6M | $2.4M | |||||
| Long Term Investments | $9.3M | $11.8M | $9.4M | $28.6M | $6.4M | ||||
| Liabilities Noncurrent | $3.6M | $4.9M | $10.2M | $11.6M | |||||
| Restricted Cash And Cash Equivalents Noncurrent | $77.0K | $79.0K | $240.0K | ||||||
| Decreaseincrease In Receivables And Prepaid Expenses | -$1.2M | -$83.0K | $1.9M | -$69.0K | -$306.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.2M | $10.1M | -$3.5M | ||||||
| Total Longterm Liabilities | $11.6M | $199.0K | $193.0K | $12.5M | |||||
| Other Liabilities Noncurrent | $400.0K | $396.0K | $398.0K | ||||||
| Assets Noncurrent | $7.1M | $8.6M | $9.3M | ||||||
| Other Payables And Accrued Expenses | $3.9M | $1.9M | $998.0K | ||||||
| Long Term Debt Noncurrent | $634.0K | $6.4M | |||||||
| Contract With Customer Liability Noncurrent | $2.5M | $2.5M | $2.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $4.9M | $2.8M | $3.4M | $4.3M | $4.8M | $4.6M | $976.0K | $995.0K |
| Net Cash Provided By Used In Operating Activities | -$27.9M | -$22.0M | -$17.2M | -$34.3M | -$32.4M | -$21.6M | -$17.4M | -$16.7M |
| Net Cash Provided By Used In Investing Activities | -$6.7M | -$330.0K | $3.8M | $16.6M | $36.9M | -$40.8M | -$23.6M | $11.0M |
| Net Cash Provided By Used In Financing Activities | $25.4M | $32.4M | $10.0M | $16.4M | $1.0M | $62.8M | $37.7M | $9.4M |
| Increase Decrease In Accounts Payable Trade | $180.0K | $1.6M | -$369.0K | -$3.1M | $2.2M | -$607.0K | $449.0K | -$887.0K |
| Proceeds From Stock Options Exercised | $1.0K | $9.0K | $108.0K | $402.0K | $3.0K | $7.0K | $24.0K | |
| Payments To Acquire Property Plant And Equipment | $210.0K | $76.0K | $196.0K | $1.8M | $2.7M | $781.0K | $879.0K | $3.1M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$481.0K | -$1.4M | $2.0M | $847.0K | -$1.5M | $560.0K | ||
| Proceeds From Issuance Of Warrants | $32.6M | $35.9M | $12.7M | $5.0M | $1.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $225.0K | $315.0K | -$641.0K | -$1.2M | -$83.0K | |||
| Payments To Acquire Short Term Investments | $26.2M | $21.4M | $18.6M | $7.0M | $8.0M | |||
| Increase Decrease In Other Operating Assets | -$907.0K | -$824.0K | -$593.0K | $40.0K | $12.0K | -$11.0K | -$5.0K | |
| Increase Decrease In Operating Lease Liability | -$675.0K | -$723.0K | -$494.0K | $2.1M | ||||
| Proceeds From Other Deposits | $19.7M | $21.1M | $22.6M | $25.3M | $47.9M | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $172.0K | $493.0K | -$481.0K | -$1.4M | ||||
| Proceeds From Warrant Exercises | $632.0K | $13.0K | ||||||
| Employee Benefits And Share Based Compensation | $4.3M | $4.8M | $4.6M | $976.0K | $995.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 16.4M | 5.9M | 1.4M | 647.6K | 624.1K | 9.6M | 562.5K | 613.4K |
| Earnings Per Share Basic | $2.09 | $4.91 | $16.99 | $61.09 | $68.27 | $4.48 | $23.69 | $-0.16 |
| Earnings Per Share Diluted | $2.09 | $4.91 | $16.93 | $61.09 | $68.27 | $4.48 | $23.69 | $0.86 |
| Weighted Average Number Of Shares Outstanding Basic | 16.4M | 5.9M | 1.4M | 647.6K | 624.1K | 9.6M | 562.5K | 561.1K |
| Common Stock Shares Outstanding | 18.2M | 10.2M | 1.7M | 669.6K | 18.8M | 18.5M | 562.7K | |
| Common Stock Shares Issued | 18.2M | 10.2M | 1.7M | 669.6K | 18.8M | 18.5M | 562.7K | |
| Common Stock Shares Authorized | 107.8M | 107.8M | 107.8M | 47.8M | 47.8M | 47.8M | 22.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $9.0K | $108.0K | $402.0K | $3.0K | $7.0K | $24.0K | |
| Depreciation | $1.5M | $1.6M | $1.8M | $1.7M | $1.1M | $1.0M | $947.0K | $411.0K |
| Marketing And Advertising Expense | $2.0M | $945.0K | $1.2M | $2.9M | $3.0M | |||
| Stock Issued During Period Value New Issues | $8.7M | $4.4M | $6.2M | $3.8M | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.9M | $2.8M | $3.4M | $4.3M | $4.8M | |||
| Marketing And Business Development Expenses | $2.9M | $3.0M | $1.6M | $887.0K | $549.0K | |||
| Interest Paid Net | $557.0K | $950.0K | $1.0M | $734.0K | ||||
| Additional Paid In Capital | $236.2M | $220.3M | $210.8M | $205.1M | $5.7M | |||
| Exercise Of Warrants | $632.0K | $13.0K | ||||||
| Net Loss Attributable To Ordinary Shares As Reported | -42.6M | -39.0M | -6.9M | 5.9M | ||||
| Adjustments To Additional Paid In Capital Warrant Issued | $115.0K | $588.0K | ||||||
| Shortterm Deposits | $22.4M | $40.2M | $22.7M | |||||
| Other Noncash Income Expense | -$697.0K | -$1.7M | -$289.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.